BioCryst to Report Fourth Quarter 2024 Financial Results on February 24
Provided By GlobeNewswire
Last update: Feb 10, 2025
RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its fourth quarter 2024 financial results on Monday, February 24, 2025.
Read more at globenewswire.com
